• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

United Therapeutics Corp

+ Add to Watchlist

UTH:GR

88.150 EUR 0.210 0.24%

As of 02:16:09 ET on 09/02/2014.

Snapshot for United Therapeutics Corp (UTH)

Open: 88.156 Day's Range: 88.150 - 89.390 Volume: 400
Previous Close: 88.360 52wk Range: 53.470 - 89.390 1-Yr Rtn: +64.86%

Stock Chart for UTH

No chart data available.
  • UTH:GR 88.150
  • 1D
  • 1M
  • 1Y
88.360
Interactive UTH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for UTH

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 12.5253
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 9.2300
Est. PEG Ratio 2.5051
Market Cap (M EUR) 4,166.80
Shares Outstanding (M) 47.27
30 Day Average Volume 49
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for UTH

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for UTH

United Therapeutics Corporation develops pharmaceuticals to treat vascular diseases such as pulmonary hypertension and peripheral vascular disease. The Company's lead products are stable synthetic forms of prostacyclin and are delivered orally or subcutaneously.

Martine A RothblattChairman/CEO/FounderRoger A JeffsPresident/COO
John M FerrariCFO/TreasurerShola OyewoleChief Information Officer
More Company Profile & Key Executives for UTH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil